Dispensed: Troubles at uBiome, pharma giant Merck's plan to upend the $20 billion HIV market, and why insurers are starting to embrace brands like SmileDirectClub

  • 📰 BusinessInsider
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 51%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Welcome to Dispensed, our weekly dispatch of healthcare, biotech, and pharma news from Business Insider.

We also got a copy of the letter the company's interim CEO sent investors on Wednesday, reassuring them about the steps the company's taking to comply with the investigations .We've also learned that George Canellos, a partner at the law firm Milbank and a former federal prosecutor, isElsewhere, Emma Court has a great look at where the field of HIV treatment is heading.

Merck has been tight-lipped about the project so far. Business Insider spoke with two top scientists about the drug and implant tech, and with HIV experts and others about how the effort could fare. Cancer has become an early focus for the technology, called targeted protein degradation or PROTAC, because there are many well-known drivers of cancer that modern medicine hasn't been able to reach.

Massive insurers like Aetna and UnitedHealthcare are embracing direct-to-consumer brands like Warby Parker and SmileDirectClub by agreeing to pay for their products.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 729. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Why insurers are beginning to embrace billion-dollar healthcare startups like SmileDirectClub and Warby ParkerMassive insurers like Aetna and UnitedHealth are starting to pay for products from direct-to-consumer brands like Warby Parker and SmileDirectClub.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Health tech start-up uBiome suspends clinical operations following FBI raiduBiome has temporarily suspended clinical operations, and will stop selling its SmartJane and SmartGut tests until further notice. This is not Thoranos in that the FBI action isn't based on belief that the product is fake, but based on fake & repeat billing of a real testing to overcharge customers.. - Health tech start-up uBiome suspends clinical operations following FBI raid Bullish.
Source: CNBC - 🏆 12. / 72 Read more »

Customer complaints show $600 million health startup uBiome has been surprising patients and insurers with bills for yearsThe FBI raided uBiome's headquarters and its co-CEOs were placed on leave. The startup has said it's cooperating with authorities. Wow.
Source: BusinessInsider - 🏆 729. / 51 Read more »

Silicon Valley's health-tech start-ups need to stop getting in so much troubleInstead of fixing the health system, Silicon Valley start-ups just keep inviting controversy.
Source: CNBC - 🏆 12. / 72 Read more »